News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Luis E. Raez: There is no really benefit adding anti-VEGF to TKIs for EGFR tumors
Photo of Luis E. Raez from X
Jan 28, 2024, 18:17

Luis E. Raez: There is no really benefit adding anti-VEGF to TKIs for EGFR tumors

Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post on X/Twitter:

“Our metanalysis in Frontiers confirming there is no really benefit adding anti-VEGF to TKIs for EGFR tumors. Congrats to the Peruvian team from Aliada for putting this together!”

Read further.

Source: Luis E. Raez/X

cancer EGFR tumors Luis E. Raez Memorial Cancer Institute OncoDaily Oncology
Career
Jul 4, 2024, 12:02
Sarah Cohen-Gogo: I'm starting a new position as Assistant Professor at University of Toronto
Insight
Jul 4, 2024, 11:59
Mina L. Xu: The power of Hi-C genomic analysis in uncovering lymphoma biology
Blog
Jul 4, 2024, 11:51
Emma B. Holliday: Some unsolicited advice for new radoncs
Insight
Jul 4, 2024, 11:44
Piotr Wysocki: 18F-PSMA-PET/CT beats multiparametric MRI in staging high-risk and intermediate-risk prostate cancers
Blog
Jul 4, 2024, 11:35
Peculiarities of Tumor Lysis Syndrome in Cancer Therapeutics - Chibuike Okafor
Dialogues
Jul 4, 2024, 11:33
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
Blog
Jul 4, 2024, 11:21
Florian Lordick: New first-line treatment algorithm for advanced gastric cancer published in ESMO
Insight
Jul 4, 2024, 11:09
Impact of Antibiotic Preconditioning on Microbiome and Immunity
Blog
Jul 4, 2024, 11:05
Christoph Varenhorst: Reflecting on a Quarter Century of Impact in Healthcare
Insight
Jul 4, 2024, 10:52
Myeloma Paper of the Day, July 4th, suggested by Robert Orlowski
Blog
Jul 4, 2024, 10:51
Toni Choueiri: Some major changes for systemic therapies in the updated NCCN guidelines are in
Positive
Jul 4, 2024, 10:46
Dr. Eytan Stein to lead a novel clinical trial for AML patients